NEVRARGENICS
NEVRARGENICS
Social Links:
Founded:
2019-01-01
Address:
Durham, Durham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.rar-mtherapeutics.co.uk
Total Employee:
1+
Status:
Active
Similar Organizations
Nanovector
Nanovector is a pharmaceutical company.
Tecnifar
Tecnifar is a pharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.rar-mtherapeutics.co.uk
Unable to get host informations!!!
More informations about "Nevrargenics"
NEVRARGENICS LIMITED - Companies House
RAR-M THERAPEUTICS LIMITED 18 Dec 2019 - 10 Nov 2020 Tell us what you think of this service (link opens a new window) Is there anything wrong with this page? (link opens a new …See details»
RAR-M Therapeutics - Facebook
RAR-M Therapeutics. 25 likes. RAR-M is developing neurodegenerative disease drugs, particularly for tackling ALSSee details»
Nevrargenics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Nevrargenics. Use the PitchBook Platform to explore the full profile.See details»
This site uses cookies - gtr.ukri.org
We have created the Spin-out company RAR-M therapeutics in December 2019 with the aim to take the most promising compounds with neuroregenerative properties towards the treatment …See details»
Nevrargenics - novel drugs for neurodegenerative diseases
Business Overview. Nevrargenics Ltd is a UK drug discovery and development company focused on innovative and novel medicines for neurodegenerative disease as well as other medical …See details»
RAR-M Therapeutics - Company Profile - Tracxn
RAR-M Therapeutics - Developer of therapeutics to treat ALS. This company is not active anymore. RAR-M Therapeutics has 485 competitors.See details»
Nevrargenics Limited in Durham, DH1 1TT - bizdb.co.uk
Dec 18, 2019 The company is situated in Durham with reg. no. 12369627. The company was set up in 2019. The headquarters of the company is located at Unit 31A Ouse House Mandale …See details»
Nevrargenics Limited. Head office in Durham. Check Director.
Once, it was called Rar-M Therapeutics Limited (it was changed on 2020-11-10). Situated at Unit 31A Ouse House Mandale Park, Belmont Industrial Estate, Durham DH1 1TT, the above …See details»
Nevrargenics Limited DURHAM - BizStats
According to CH data there was a name change on 2020-11-10 and their previous name was Rar-M Therapeutics Limited. The last confirmation statement was filed on 2023-07-06 and the …See details»
Nevrargenics Limited. net worth, address, company information. Free
This firm is situated at Unit 31A Ouse House Mandale Park, Belmont Industrial Estate, Durham DH1 1TT. Having undergone a change in 2020-11-10, the previous name the business used …See details»
Corporate Council Members - National Organization for Rare …
NORD is a registered 501(c)(3) charity organization. Please note that NORD provides this information for the benefit of the rare disease community. NORD is not a medical provider or …See details»
Rar-mtherapeutics : rar-mtherapeutics.com
Rar-mtherapeutics.com is 4 years 5 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats …See details»
RAR-M Therapeutics - 401 Competitors and Alternatives - Tracxn
RAR-M Therapeutics has 401 active competitors. Competitors include Biogen, Amylyx Pharmaceuticals.See details»
NIH, FDA and 15 private organizations join forces to increase …
October 27, 2021 – The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate …See details»
Retinoic acid receptor-targeted drugs in neurodegenerative …
Sep 2, 2020 McCaffery is a non-executive director of Nevrargenics Ltd. and both Whiting and McCaffery have patents on RAR directed ligands. The authors have no other relevant …See details»
RAR PHARMACEUTICS LTD Company Profile - Dun & Bradstreet
Rar pharmaceutics ltd. d&b business directory home / business directory / wholesale trade / merchant wholesalers, nondurable goods / drugs and druggists' sundries merchant …See details»
Keros Therapeutics Announces Initial Topline Results from the …
LEXINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and …See details»
Update on hydromethylthionine mesylate application to UK …
Dec 31, 2024 Company statement in response to recent media stories regarding HMTM: TauRx continues to liaise with both the Medicines and Healthcare products Regulatory Agency …See details»
Saving shelved ultra-rare therapies through unorthodox funding
16 hours ago Deanna Porto (DP): Our goal at Orphan Therapeutics Accelerator is to provide a sustainable path for the development and access of patients to ultra-rare therapies. We …See details»
Rare Disease Innovation and Data Sharing Accelerated by New …
Sep 15, 2021 The National Organization for Rare Disorders (NORD) is the leading independent advocacy organization representing all patients and families affected by rare diseases in the …See details»